LILRB1-Directed CAR-T Cells for the Treatment of Hematological Malignancies

0
1512
Researchers observed stable LILRB1 expression in B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma, even after CD20/CD19-based immunotherapies.
[Leukemia]
Full Article